User profiles for P. J. Gow

Paul Gow

Austin Hospital
Verified email at Austin.org.au
Cited by 6505

sarcopenia in cirrhosis–aetiology, implications and potential therapeutic interventions

M Sinclair, PJ Gow, M Grossmann… - Alimentary …, 2016 - Wiley Online Library
Gow contributed towards formulating the draft of the manuscript and critical revision. Peter
W Angus contributed towards formulating the draft of the manuscript and critical revision. …

Testosterone in men with advanced liver disease: abnormalities and implications

M Sinclair, M Grossmann, PJ Gow… - … of gastroenterology and …, 2015 - Wiley Online Library
Serum testosterone is reduced in up to 90% of men with cirrhosis, with levels falling as liver
disease advances. Testosterone is an important anabolic hormone, with effects on muscle, …

Neonatal hepatic drug elimination

PJ Gow, H Ghabrial, RA Smallwood… - Pharmacology & …, 2001 - Wiley Online Library
After the transition from in utero to newborn life, the neonate becomes solely reliant upon its
own drug clearance processes to metabolise xenobiotics. Whilst most studies of neonatal …

Diagnosis of Wilson's disease: an experience over three decades

PJ Gow, RA Smallwood, PW Angus, AL Smith, AJ Wall… - Gut, 2000 - gut.bmj.com
BACKGROUND Wilson's disease is a rare but treatable condition that often presents diagnostic
dilemmas. These dilemmas have for the most part not been resolved by the identification …

National prevalence of gout derived from administrative health data in Aotearoa New Zealand

…, WJ Taylor, G Jackson, L Te Karu, PJ Gow… - …, 2012 - academic.oup.com
Objective. Previous small studies in Aotearoa New Zealand have indicated a high prevalence
of gout. This study sought to determine the prevalence of gout in the entire Aotearoa New …

Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial

…, M Grossmann, R Hoermann, PW Angus, PJ Gow - Journal of …, 2016 - Elsevier
… Marie Sinclair, Mathis Grossmann, Peter Angus and Paul Gow contributed to planning of
the trial, drafting and finalising of the manuscript. Day-to-day trial proceedings were conducted …

Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C

M Wali, RF Harrison, PJ Gow, D Mutimer - Gut, 2002 - gut.bmj.com
Background and aims: Cirrhosis with liver failure due to hepatitis C virus (HCV) infection is
the most common indication for liver transplantation (LT). Reinfection of the transplanted liver …

Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis

…, ME Merriman, PT Chapman, PJ Gow… - Annals of the …, 2008 - ard.bmj.com
Objective: There is increasing evidence that gene copy-number variation influences
phenotypic variation. Chemokine ligand 3-like 1 (CCL3L1) is encoded by a variable copy-number …

Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case–control sample sets

…, R Topless, C Waddell, PJ Gow… - … : Official Journal of …, 2009 - Wiley Online Library
Objective To examine the role of genetic variation in the renal urate transporter SLC2A9 in
gout in New Zealand sample sets of Māori, Pacific Island, and Caucasian ancestry and to …

Epidemiology of primary biliary cirrhosis in Victoria, Australia: high prevalence in migrant populations

S Sood, PJ Gow, JM Christie, PW Angus - Gastroenterology, 2004 - Elsevier
Background & Aims : The prevalence of primary biliary cirrhosis (PBC) reported in different
countries varies widely, indicating that genetic or environmental factors may be important in …